Design and characterization of a novel fluorinated magnetic resonance imaging agent for functional analysis of bile acid transporter activity

Diana Vivian, Kunrong Cheng, Sandeep Khurana, Su Xu, Valerie Whiterock, Drew Witter, Kimberley A. Lentz, Kenneth S. Santone, Jean Pierre Raufman, James E. Polli

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Purpose: To synthesize a trifluorinated bile acid that can be used for 19F magnetic resonance imaging (MRI) of bile acid enterohepatic circulation, characterize its in vitro transporter affinity, stability, and 19F-MRI signal, and assess its ability to concentrate in the gallbladder of C57BL/6 mice. Methods: Target compound CA-lys-TFA was synthesized and tested for affinity toward the apical sodium dependent bile acid transporter (hASBT) and the Na+/taurocholate cotransporting polypeptide (hNTCP). In a pilot study, fasted mice were gavaged with vehicle control, 150 mg/kg or 300 mg/kg CA-lys-TFA. CA-lys-TFA in gallbladder, liver and plasma at t = 5 h was quantified. Additionally, a 24-h time course (24 mice across eight time points) was studied using 50 mg/kg CA-lys-TFA. Results: CA-lys-TFA was a potent substrate of hASBT (Kt = 39.4 μM, normalized Vmax = 0.853) and hNTCP (Kt = 8.99 μM, normalized Vmax = 0.281). 19F MRI phantom imaging showed linear signal-concentration dependence. In vivo studies showed that rapid accumulation of CA-lys-TFA in the gallbladder was maximal within 4-7 h. Conclusions: These findings suggest that CA-lys-TFA, a fluorinated non-radioactive bile acid analogue, has potential for use in MRI to measure in vivo bile acid transport and diagnose bile acid malabsorption and other conditions associated with impaired bile acid transport.

Original languageEnglish (US)
Pages (from-to)1240-1251
Number of pages12
JournalPharmaceutical Research
Volume30
Issue number5
DOIs
StatePublished - May 1 2013

Fingerprint

Functional analysis
Magnetic resonance
Bile Acids and Salts
Magnetic Resonance Imaging
Imaging techniques
Gallbladder
Taurocholic Acid
Imaging Phantoms
Enterohepatic Circulation
Peptides
Inbred C57BL Mouse
Liver
bile acid binding proteins
Plasmas
Substrates

Keywords

  • Na+/taurocholate cotransporting polypeptide
  • apical sodium-dependent bile acid transporter
  • bile acid transport
  • enterohepatic circulation
  • fluorine MRI

ASJC Scopus subject areas

  • Pharmaceutical Science
  • Organic Chemistry
  • Molecular Medicine
  • Pharmacology (medical)
  • Biotechnology
  • Pharmacology

Cite this

Design and characterization of a novel fluorinated magnetic resonance imaging agent for functional analysis of bile acid transporter activity. / Vivian, Diana; Cheng, Kunrong; Khurana, Sandeep; Xu, Su; Whiterock, Valerie; Witter, Drew; Lentz, Kimberley A.; Santone, Kenneth S.; Raufman, Jean Pierre; Polli, James E.

In: Pharmaceutical Research, Vol. 30, No. 5, 01.05.2013, p. 1240-1251.

Research output: Contribution to journalArticle

Vivian, D, Cheng, K, Khurana, S, Xu, S, Whiterock, V, Witter, D, Lentz, KA, Santone, KS, Raufman, JP & Polli, JE 2013, 'Design and characterization of a novel fluorinated magnetic resonance imaging agent for functional analysis of bile acid transporter activity', Pharmaceutical Research, vol. 30, no. 5, pp. 1240-1251. https://doi.org/10.1007/s11095-012-0963-6
Vivian, Diana ; Cheng, Kunrong ; Khurana, Sandeep ; Xu, Su ; Whiterock, Valerie ; Witter, Drew ; Lentz, Kimberley A. ; Santone, Kenneth S. ; Raufman, Jean Pierre ; Polli, James E. / Design and characterization of a novel fluorinated magnetic resonance imaging agent for functional analysis of bile acid transporter activity. In: Pharmaceutical Research. 2013 ; Vol. 30, No. 5. pp. 1240-1251.
@article{c432e72b73744bf8b0e644fa6e241e6a,
title = "Design and characterization of a novel fluorinated magnetic resonance imaging agent for functional analysis of bile acid transporter activity",
abstract = "Purpose: To synthesize a trifluorinated bile acid that can be used for 19F magnetic resonance imaging (MRI) of bile acid enterohepatic circulation, characterize its in vitro transporter affinity, stability, and 19F-MRI signal, and assess its ability to concentrate in the gallbladder of C57BL/6 mice. Methods: Target compound CA-lys-TFA was synthesized and tested for affinity toward the apical sodium dependent bile acid transporter (hASBT) and the Na+/taurocholate cotransporting polypeptide (hNTCP). In a pilot study, fasted mice were gavaged with vehicle control, 150 mg/kg or 300 mg/kg CA-lys-TFA. CA-lys-TFA in gallbladder, liver and plasma at t = 5 h was quantified. Additionally, a 24-h time course (24 mice across eight time points) was studied using 50 mg/kg CA-lys-TFA. Results: CA-lys-TFA was a potent substrate of hASBT (Kt = 39.4 μM, normalized Vmax = 0.853) and hNTCP (Kt = 8.99 μM, normalized Vmax = 0.281). 19F MRI phantom imaging showed linear signal-concentration dependence. In vivo studies showed that rapid accumulation of CA-lys-TFA in the gallbladder was maximal within 4-7 h. Conclusions: These findings suggest that CA-lys-TFA, a fluorinated non-radioactive bile acid analogue, has potential for use in MRI to measure in vivo bile acid transport and diagnose bile acid malabsorption and other conditions associated with impaired bile acid transport.",
keywords = "Na+/taurocholate cotransporting polypeptide, apical sodium-dependent bile acid transporter, bile acid transport, enterohepatic circulation, fluorine MRI",
author = "Diana Vivian and Kunrong Cheng and Sandeep Khurana and Su Xu and Valerie Whiterock and Drew Witter and Lentz, {Kimberley A.} and Santone, {Kenneth S.} and Raufman, {Jean Pierre} and Polli, {James E.}",
year = "2013",
month = "5",
day = "1",
doi = "10.1007/s11095-012-0963-6",
language = "English (US)",
volume = "30",
pages = "1240--1251",
journal = "Pharmaceutical Research",
issn = "0724-8741",
publisher = "Springer New York",
number = "5",

}

TY - JOUR

T1 - Design and characterization of a novel fluorinated magnetic resonance imaging agent for functional analysis of bile acid transporter activity

AU - Vivian, Diana

AU - Cheng, Kunrong

AU - Khurana, Sandeep

AU - Xu, Su

AU - Whiterock, Valerie

AU - Witter, Drew

AU - Lentz, Kimberley A.

AU - Santone, Kenneth S.

AU - Raufman, Jean Pierre

AU - Polli, James E.

PY - 2013/5/1

Y1 - 2013/5/1

N2 - Purpose: To synthesize a trifluorinated bile acid that can be used for 19F magnetic resonance imaging (MRI) of bile acid enterohepatic circulation, characterize its in vitro transporter affinity, stability, and 19F-MRI signal, and assess its ability to concentrate in the gallbladder of C57BL/6 mice. Methods: Target compound CA-lys-TFA was synthesized and tested for affinity toward the apical sodium dependent bile acid transporter (hASBT) and the Na+/taurocholate cotransporting polypeptide (hNTCP). In a pilot study, fasted mice were gavaged with vehicle control, 150 mg/kg or 300 mg/kg CA-lys-TFA. CA-lys-TFA in gallbladder, liver and plasma at t = 5 h was quantified. Additionally, a 24-h time course (24 mice across eight time points) was studied using 50 mg/kg CA-lys-TFA. Results: CA-lys-TFA was a potent substrate of hASBT (Kt = 39.4 μM, normalized Vmax = 0.853) and hNTCP (Kt = 8.99 μM, normalized Vmax = 0.281). 19F MRI phantom imaging showed linear signal-concentration dependence. In vivo studies showed that rapid accumulation of CA-lys-TFA in the gallbladder was maximal within 4-7 h. Conclusions: These findings suggest that CA-lys-TFA, a fluorinated non-radioactive bile acid analogue, has potential for use in MRI to measure in vivo bile acid transport and diagnose bile acid malabsorption and other conditions associated with impaired bile acid transport.

AB - Purpose: To synthesize a trifluorinated bile acid that can be used for 19F magnetic resonance imaging (MRI) of bile acid enterohepatic circulation, characterize its in vitro transporter affinity, stability, and 19F-MRI signal, and assess its ability to concentrate in the gallbladder of C57BL/6 mice. Methods: Target compound CA-lys-TFA was synthesized and tested for affinity toward the apical sodium dependent bile acid transporter (hASBT) and the Na+/taurocholate cotransporting polypeptide (hNTCP). In a pilot study, fasted mice were gavaged with vehicle control, 150 mg/kg or 300 mg/kg CA-lys-TFA. CA-lys-TFA in gallbladder, liver and plasma at t = 5 h was quantified. Additionally, a 24-h time course (24 mice across eight time points) was studied using 50 mg/kg CA-lys-TFA. Results: CA-lys-TFA was a potent substrate of hASBT (Kt = 39.4 μM, normalized Vmax = 0.853) and hNTCP (Kt = 8.99 μM, normalized Vmax = 0.281). 19F MRI phantom imaging showed linear signal-concentration dependence. In vivo studies showed that rapid accumulation of CA-lys-TFA in the gallbladder was maximal within 4-7 h. Conclusions: These findings suggest that CA-lys-TFA, a fluorinated non-radioactive bile acid analogue, has potential for use in MRI to measure in vivo bile acid transport and diagnose bile acid malabsorption and other conditions associated with impaired bile acid transport.

KW - Na+/taurocholate cotransporting polypeptide

KW - apical sodium-dependent bile acid transporter

KW - bile acid transport

KW - enterohepatic circulation

KW - fluorine MRI

UR - http://www.scopus.com/inward/record.url?scp=84876488722&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84876488722&partnerID=8YFLogxK

U2 - 10.1007/s11095-012-0963-6

DO - 10.1007/s11095-012-0963-6

M3 - Article

VL - 30

SP - 1240

EP - 1251

JO - Pharmaceutical Research

JF - Pharmaceutical Research

SN - 0724-8741

IS - 5

ER -